Ryan Bennett joined OyaGen in 2007. Dr. Bennett earned
his BS in Biology/Chemistry from Elmira College in 2001 and his PhD
from the Department of Biochemistry at the University of Rochester,
School of Medicine and Dentistry in 2007.
He received a National Institute of Health HIV Training
Grant Fellowship in 2005, 2006, and 2007. He also received an RNA Society
award for best graduate student poster at the Gordon Research Conference on
RNA Editing in January 2007. He pursued his graduate research on the
multifaceted functions of the HIV-1 antiviral protein APOBEC3G under the
direction of Professor Harold C. Smith the founder of OyaGen.
Ryan’s focus at OyaGen is on assay development around the
APOBEC3G/Vif platform and secondary analysis of small molecule hits from
High Throughput Screening.
Publications
Bennett RP, Salter JD, Liu X, Wedekind JE, Smith HC. APOBEC3G
subunits self-associate via the C-terminal deaminase domain. J Biol
Chem in press (2008).
Bennett RP, Presnyak V, Wedekind JE, Smith HC. Nuclear exclusion of
the HIV-1 host defense factor APOBEC3G requires a novel cytoplasmic
retention signal. J Biol Chem 283, 7320-7(2008).
Bennett RP, Diner E, Sowden MP, Lees JA, Wedekind JE, Smith HC.
APOBEC-1 and AID are nucleo-cytoplasmic trafficking proteins but
APOBEC3G cannot traffic. Biochem Biophys Res Commun 350, 214-9
(2006).
Wedekind JE, Gillilan R, Janda A, Krucinska J, Salter JD, Bennett
RP, Raina J, Smith HC. Nanostructures of APOBEC3G support a
hierarchical assembly model of high molecular mass ribonucleoprotein
particles from dimeric subunits. J Biol Chem 281, 38122-6 (2006).
Jin X, Brooks A, Chen H, Bennett R, Reichman R, and Smith H.
APOBEC3G/CEM15 (hA3G) mRNA Levels Associate Inversely with Human
Immunodeficiency Virus Viremia. J Virol 79, 11513-6 (2005).
Tomari Y, Du T, Haley B, Schwarz DS, Bennett R, Cook HA, Koppetsch
BS, Theurkauf WE, Zamore PD. RISC Assembly Defects in the Drosophila
RNAi Mutant armitage. Cell 116, 831-41 (2004).